Borregaard ASA (BRGAY)
35.15
0.00 (0.00%)
USD |
OTCM |
Dec 16, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 1.753B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 15.93% |
Valuation | |
PE Ratio | 23.15 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 2.554 |
Price to Book Value | 3.608 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.6790 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.4408 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | -- |
Profile
Borregaard ASA makes and sells biochemicals and biomaterials designed to replace oil-based products, It has three operating segments; BioSolutions segment develops, produces and sells biopolymers and bio vanillin from lignin used in Industries such as agrochemicals, batteries, industrial binders and construction. Bio vanillin is supplied to flavour and fragrance companies, as well as to the food and beverage industry, Biomaterials segment develops, produces and sells speciality cellulose mainly for use as a raw material in the production of cellulose ethers, cellulose acetate and other speciality products. It also includes cellulose fibrils for industrial applications, and the Fine Chemicals segment consists of fine chemical intermediates for contrast agents and bioethanol. |
URL | https://www.borregaard.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | |
Industry | |
Equity Style | Small Cap/Blend |
Next Earnings Release | Jan. 29, 2025 |
Last Earnings Release | Oct. 30, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Apr. 12, 2024 |
Ratings
Profile
Borregaard ASA makes and sells biochemicals and biomaterials designed to replace oil-based products, It has three operating segments; BioSolutions segment develops, produces and sells biopolymers and bio vanillin from lignin used in Industries such as agrochemicals, batteries, industrial binders and construction. Bio vanillin is supplied to flavour and fragrance companies, as well as to the food and beverage industry, Biomaterials segment develops, produces and sells speciality cellulose mainly for use as a raw material in the production of cellulose ethers, cellulose acetate and other speciality products. It also includes cellulose fibrils for industrial applications, and the Fine Chemicals segment consists of fine chemical intermediates for contrast agents and bioethanol. |
URL | https://www.borregaard.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | |
Industry | |
Equity Style | Small Cap/Blend |
Next Earnings Release | Jan. 29, 2025 |
Last Earnings Release | Oct. 30, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Apr. 12, 2024 |